Filter by Industry
Filter by Topic
The rise of AI-enabled medical devices
Learn how the rise of AI-enabled medical devices is poised to reshape both the quality of care for patients and the experience of care delivery for…
Turn healthcare expertise into audience reach with KOL data
With the addition of KOL data to Definitive Healthcare’s Digital Audiences, organizations can now seamlessly integrate expert audience intelligence…
Navigate the maze of healthcare with the right approach to data
Definitive Healthcare’s connected healthcare intelligence is an alternative to standalone datasets, bringing critical insights together to help…
2027 trends to watch: AI will put healthcare data foundations to the test
As healthcare organizations bring AI into more workflows, fragmented data, missing context, and weak governance could limit its impact. In 2027…
2027 trends to watch: A growing older population will intensify the burden of age-related disease
America’s growing older population has serious implications for healthcare, especially in the management of progressive and chronic conditions. Learn…
Fierce Pharma Week 2026: 4 takeaways for life sciences leaders
Explore four key takeaways from Fierce Pharma Week 2026, including AI adoption, patient-driven science, GLP-1 engagement, and HCP targeting.
Observed claims or estimated volumes? Match the data to the decision
The right healthcare claims data depends on the decision you need to make. Learn when to use observed claims versus estimated volumes to size an…
2027 trends to watch: Supply chain resilience will rewrite healthcare purchasing and partnerships
The fourth entry in the Definitive Healthcare 2027 trends series explores how organizations are building greater resilience into supply chain…
2027 trends to watch: Distributed care will drive the next phase of healthcare delivery
Explore how distributed care is reshaping healthcare delivery—and why connected data can help leaders manage costs, access, capacity, and growth.
2027 trends to watch: GLP-1s and metabolic care will reshape more than obesity treatment
With major FDA reviews slated for next year, as well as new and ongoing clinical trials, healthcare organizations must understand how the rapid…